Jeil Pharma Holdings (XKRX:002620) Long-Term Capital Lease Obligation : ₩1,120 Mil (As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Jeil Pharma Holdings Long-Term Capital Lease Obligation?

Jeil Pharma Holdings's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩1,120 Mil.

Jeil Pharma Holdings's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (₩1,219 Mil) to Dec. 2023 (₩1,198 Mil) and declined from Dec. 2023 (₩1,198 Mil) to Mar. 2024 (₩1,120 Mil).

Jeil Pharma Holdings's annual Long-Term Capital Lease Obligation declined from Dec. 2021 (₩1,576 Mil) to Dec. 2022 (₩1,177 Mil) but then increased from Dec. 2022 (₩1,177 Mil) to Dec. 2023 (₩1,198 Mil).

Jeil Pharma Holdings Long-Term Capital Lease Obligation Historical Data

The historical data trend for Jeil Pharma Holdings's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharma Holdings Long-Term Capital Lease Obligation Chart

Jeil Pharma Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

320.95

216.45

1,576.28

1,177.01

1,198.04

Jeil Pharma Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															1,119.13	1,354.26	1,219.02	1,198.04	1,119.58

Jeil Pharma Holdings (XKRX:002620) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Jeil Pharma Holdings Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Jeil Pharma Holdings's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeil Pharma Holdings (XKRX:002620) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

745-5, Banpo-dong, Seocho-gu, Seoul, KOR, 137-810

Website

https://www.jeilpharm.co.kr

Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Jeil Pharma Holdings (XKRX:002620) Headlines

No Headlines